Sponsor Pipeline

Yanjie Zhang, MD Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
2
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-07 NCT07751276 Perioperative Finotonlimab Plus Chemotherapy in Untreated Stage II HNSCC Phase 2 Not Yet Recruiting
2026-08-07 NCT07751289 Anti-PD-1 Therapy in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07646080 Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemotherapy for… Dermatofibrosarcoma Protuberans (DFSP) Not Yet Recruiting
NCT07751276 Perioperative Finotonlimab Plus Chemotherapy in Untreated Stage II HNSCC Head and Neck Squamous Cell Carcinoma HNSCC Not Yet Recruiting
NCT07751289 Anti-PD-1 Therapy in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Recurrent Head and Neck Squamous Cell Carcinoma Not Yet Recruiting
Disease Areas
Head & Neck Cancer (2) Sarcoma (1)
Get alerts when Yanjie Zhang, MD's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free